IL15 and leukemia: In each organ, there was a decreased leukemia burden and an increased frequency of human T cells in mice that had received CD123-ENG.IL15 T-cells compared to other treatment groups (Figures 4G; S7), mirroring the results of our peripheral blood analysis.